Pre-expiry and generic prices of drugs in U.S. 2015 | Statista

This statistic shows the comparison of brand pre-expiry price and generic price of select drugs in the United States in 2015. The price for Zofran was 21.67 U.S. dollars before patent expiration in 2006, whereas the generic price for the same drug was 0.24 U.S. dollars in 2015.

Comparison of brand pre-expiry price and generic price of selected drugs in the United States as of 2015 (in U.S. dollars)

Name and generic entry year	Brand Pre-Expiry Price	Generic Price 2015
Zofran (ondansetron, 2006)	21.67	0.24
Seroquel (quetiapine, 2012)	6	0.17
Plavix (clopidogrel, 2006)	4.91	0.18
Singulair (montelukast, 2012)	3.75	0.21
Prilosec (omeprazole, 2002)	3.31	0.11
Lipitor (atorvastatin, 2011)	3.29	0.14
Zocor (simvastatin, 2005)	2.62	0.03
Zoloft (sertraline, 2006)	2.18	0.06
Neurontin (gabapentin, 2004)	1.02	0.09
Norvasc (amlodipine, 2007)	1.02	0.03

Loading statistic...

Download

Source

Show detailed source information?

Register for free

Already a member?

Sources

Use Ask Statista Research Service

Release date

November 2016

More information

Region

United States

Survey time period

as of 2015

Supplementary notes

Citation formats

Other statistics on the topic

Revenue of the worldwide pharmaceutical market from 2001 to 2023 (in billion U.S. dollars)

Pharmaceutical Products & Market

Pharmaceutical market: worldwide revenue 2001-2023

Leading generics manufacturers worldwide based on revenue in 2022 (in billion U.S. dollars)

Pharmaceutical Products & Market

Revenues of leading global generics manufacturers 2022

Proportion of branded versus generic prescription drug spending in the United States from 2017 to 2021

Pharmaceutical Products & Market

U.S. brand and generic prescription drug spending 2017-2021

Leading 20 U.S. pharma products by total prescriptions in 2021 (in millions)

Pharmaceutical Products & Market

Top pharma products by prescriptions U.S. 2021

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Starter Account

The ideal entry-level account for individual users

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$199 USD / Month *

Professional Account

Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in India

Global pharmaceutical industry

Pharmaceutical industry in Japan

Pharmaceutical industry in China

Pharmaceutical industry in South Korea

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year

Learn more about how Statista can support your business.